COVID-19 Supplemental work: NON-HUMAN PRIMATE MAJOR HISTOCOMPATIBILITY COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT.

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201600027C-P00008-9999-3

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2020
  • Known Financial Commitments (USD)

    $528,451
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    MEMBER. DANIEL GERAGHTY
  • Research Location

    United States of America
  • Lead Research Institution

    FRED HUTCHINSON CANCER RESEARCH CENTER
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The study will validate a NGS-based COVID-19 detection system for unambiguous sequence-based reporting using residual materials / isolated total nucleic acids remaining after a RT-PCR based COVID-19 testing is performed.